SC
Scope Fluidics S.A.
SCP.WA · WSE
129.00 zł -0.77% (-1.00 zł)
1M -5.43%
Market Cap 411.2M zł
P/E Ratio -
Div. Yield -
ROE 35.29%
Bulios Fair Price
91.31 zł
29.2% downside
Current Price
129 zł
Undervalued Fair Value Overvalued
According to Bulios Fair Price, SCP.WA is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
1/9Valuation
36 /100
Fair P/B 2.76x
P/S 3,954.24x
P/FFO N/A
Growth
0 /100
Declining Book val. growth 21.28%
Rev. growth 37.21%
FCF growth N/A
Profitability
0 /100
Weak Net margin 46,959.60%
Op. margin 49,404.80%
FCF margin 58,067.30%
Quality
0 /100
Poor ROE 35.29%
ROA 26.76%
Asset turnover 0.00x
Debt
69 /100
Low Current ratio 11.81x
Int. coverage -28.56x
Debt/Equity 0.12x
Stability
1 /100
Unstable Rev. volatility 51.17%
EPS volatility 339.92%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about SCP.WA
Online
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Piotr Garstecki
Employees
157
Headquarters
Warsaw